Skip to main content

Table 1 Demographic and clinical characteristics of the study population at study entry

From: Components of metabolic syndrome in patients with multiple myeloma and smoldering multiple myeloma

Parameter Multiple myeloma Smoldering multiple myeloma Controls P-value
Number 105 48 138  
Age, yr (SD) 64.5 (12.5) 67.8 (9.4) 64.5 (4.8) .071
Male (%) 54 (51.4) 27 (56.3) 80 (57.2) .653
BMI, kg/m2 (SD) 27.6 (4.8) 26.2 (4.1) 27.2 (3.8) .483
Diabetes (%) 28 (26.5)a 12 (25.0)a 11 (8.0)b <.001
Hypertension (%) 56 (53.3)ab 29 (60.4)a 57 (41.3)b .034
Dyslipidemia (%) 43 (41.3)ab 26 (54.2)a 44 (31.9)b .020
IHD (%) 13 (12.5) 7 (14.6) 11 (6.5) .153
  1. SD standard deviation, BMI body mass index, IHD ischemic heart disease
  2. a and bUsed to discriminate within-group difference
  3. aStatistically different fromb
  4. abIntermediate group which does not differ from either a or b